InTandem and the creation of its Vivo Infusion platform, Iconiq is back with its next growth flagship

Iconiq goes back to market with a new fund.

23 March 2022•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.